openPR Logo
Press release

Leukocyte Surface Antigen CD47 Antibody Market to Reach USD 6 Billion by 2034, Growing at a 10.3% CAGR

06-06-2025 09:17 AM CET | Health & Medicine

Press release from: Exactitude Consultancy

Leukocyte Surface Antigen CD47 Antibody

Leukocyte Surface Antigen CD47 Antibody

As of 2024, the global market for Leukocyte Surface Antigen CD47 Antibody is valued at approximately $2.5 billion, driven by increased research funding, heightened awareness of immune checkpoint inhibitors, and growing prevalence of cancer and autoimmune diseases. The market is expected to expand significantly, reaching an estimated $6 billion by 2034, reflecting a robust Compound Annual Growth Rate (CAGR) of around 10.3% during the forecast period from 2025 to 2034.

Exactitude Consultancy., Ltd. released a research report offers a comprehensive examination of the various processes and materials used in the production of Leukocyte Surface Antigen CD47 Antibody market goods. The market study excludes key regions that are accelerating marketization. This section also gives the extent of different market segments and applications that could have an impact on the market in the future. Current trends and historical turning points form the basis of the enormous amount of data. The report includes information on market trends and development, growth drivers, emerging technologies, and the investment structure of the Leukocyte Surface Antigen CD47 Antibody market.

This report is also available in the following languages : Japanese (白血球表面抗原CD47抗体), Korean (백혈구 표면 항원 CD47 항체), Chinese (白细胞表面抗原CD47抗体), French (Anticorps anti-antigène de surface des leucocytes CD47), German (Leukozyten-Oberflächenantigen CD47-Antikörper), and Italian (Anticorpo antigene di superficie leucocitario CD47), etc.

Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/66237

Key Companies:
Johnson & Johnson , Bristol-Myers Squibb , AbbVie , Amgen , Genentech (a member of the Roche Group) , Gilead Sciences , Regeneron Pharmaceuticals , Novartis , Merck & Co. , Sanofi , Pfizer , Biogen , AstraZeneca , Takeda Pharmaceutical Company , Eli Lilly and Company

Market Segmentation
By Product Type
Monoclonal Antibodies
Polyclonal Antibodies

By Application
Cancer Treatment
Autoimmune Diseases
Research Applications

By End User
Pharmaceutical Companies
Research Laboratories
Academic Institutions

By Technology
Recombinant DNA Technology
Hybridoma Technology

By Distribution Channel
Online Sales
Direct Sales
Retail Pharmacies

Explore Full Report here: https://exactitudeconsultancy.com/reports/66237/leukocyte-surface-antigen-cd47-antibody-market

If opting for the Global version of Leukocyte Surface Antigen CD47 Antibody Market; then the below country analysis would be included:

- North America (the USA, Canada, and Mexico)
- Europe (Germany, France, the United Kingdom, Netherlands, Italy, Nordic Nations, Spain, Switzerland, and the Rest of Europe)
- Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India, Southeast Asia, and the Rest of APAC)
- South America (Brazil, Argentina, Chile, Colombia, the Rest of the countries, etc.)
- the Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Turkey, Nigeria, South Africa, Rest of MEA)

Buy Now @ https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=66237

The report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios of the top players in the Leukocyte Surface Antigen CD47 Antibody market.
Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.
Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Leukocyte Surface Antigen CD47 Antibody market.

Get Your Exclusive Offer with up to 30% Discount : https://exactitudeconsultancy.com/check-discount/66237

Reasons To Buy The Leukocyte Surface Antigen CD47 Antibody Market Report:

➼ In-depth analysis of the market on the global and regional levels.
➼ Major changes in market dynamics and competitive landscape.
➼ Segmentation on the basis of type, application, geography, and others.
➼ Historical and future market research in terms of size, share growth, volume, and sales.
➼ Major changes and assessment in market dynamics and developments.
➼ Emerging key segments and regions
➼ Key business strategies by major market players and their key methods

Our team is available 24/7 to assist and support our customers through reliable research.

Customization
-20% free customization.
-Five Countries can be added as per your choice.
-Five Companies can added as per your choice.
-Free customization up to 40 hours.
-Post-sales support for 1 year from the date of delivery.

Other Reports:

Urine Collection Cup Market
https://exactitudeconsultancy.com/reports/65598/urine-collection-cup-market

Medical Disposable Curtain Market
https://exactitudeconsultancy.com/reports/65638/medical-disposable-curtain-market

Ginger Root Supplement Market
https://exactitudeconsultancy.com/reports/65678/ginger-root-supplement-market

Post Mortem Knives Market
https://exactitudeconsultancy.com/reports/65718/post-mortem-knives-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Leukocyte Surface Antigen CD47 Antibody Market to Reach USD 6 Billion by 2034, Growing at a 10.3% CAGR here

News-ID: 4054684 • Views:

More Releases from Exactitude Consultancy

Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitation and Infrastructure Projects
Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitatio …
The global cold planer market is experiencing steady growth as governments and private contractors increase spending on road rehabilitation, resurfacing, and infrastructure modernization. Cold planers, also known as milling machines, are widely used to remove damaged asphalt and concrete surfaces efficiently, supporting sustainable road construction practices. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68250 Key Market Highlights • Increasing focus on road maintenance and resurfacing projects • Growing demand for efficient and precision milling
Credit Management Software Market Accelerates as Organizations Focus on Risk Mitigation and Cash Flow Optimization
Credit Management Software Market Accelerates as Organizations Focus on Risk Mit …
The global credit management software market is witnessing robust growth as organizations across industries adopt digital solutions to manage credit risk, improve receivables performance, and strengthen financial controls. Credit management software enables businesses to automate credit scoring, monitor customer creditworthiness, and streamline collections processes. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68248 Key Market Highlights • Growing adoption of automated credit risk assessment tools • Increasing focus on working capital and cash flow management • Integration
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Operators Strengthen Network Security
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Oper …
The global session border controller (SBC) market is experiencing strong growth as telecom operators and enterprises increasingly deploy SBC solutions to secure, manage, and optimize real-time IP communications. SBCs play a critical role in protecting voice over IP (VoIP), unified communications (UC), and multimedia sessions from cyber threats while ensuring interoperability and quality of service. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68246 Key Market Highlights • Growing adoption of VoIP and
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Traction Amid Global Decarbonization Efforts
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Tr …
The global biofuel market, encompassing e-methane, sustainable aviation fuel (SAF), and other advanced biofuels, is witnessing robust growth as governments and industries intensify efforts to reduce carbon emissions and transition toward cleaner energy sources. These fuels play a critical role in achieving net-zero targets while enabling decarbonization of hard-to-abate sectors such as aviation, shipping, and heavy transportation. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68244 Key Market Highlights • Rapid growth of

All 5 Releases


More Releases for CD47

Anti-CD47 Drugs Market to Set Phenomenal Growth From 2025 to 2034
CD47, a cell surface glycoprotein, plays a critical role in regulating immune responses and cell signaling. Often referred to as the "don't eat me" signal, CD47 interacts with its receptor, SIRPα (signal regulatory protein alpha), on macrophages and other immune cells to inhibit phagocytosis, or the process by which immune cells engulf and destroy foreign or damaged cells. Many cancer cells overexpress CD47, which helps them evade immune detection and
CD47 Targeting Therapeutics Market Robust Expansion is expected to 2034
CD47 Targeting Therapeutics Market Future Pipeline/Clinical Trial Analysis and Revenue Forecast Snapshot - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "CD47 Targeting Therapeutics Market By Target Disease Indication (Acute Myeloid Leukemia, Non-Hodgkin Lymphoma, Colorectal Cancer, Diffuse Large B-cell Lymphoma, Myelodysplastic Syndromes, Non-Small Cell Lung Cancers, Ovarian Epithelial Cancer, Oral mucositis, Small Cell Lung Cancers, Other Diseases Indications), By
CD47 Targeting Therapeutics Market Investments, Share and Revenue Analysis Repor …
CD47 Targeting Therapeutics Market Future Pipeline/Clinical Trial Analysis and Revenue Forecast Snapshot - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "CD47 Targeting Therapeutics Market By Target Disease Indication (Acute Myeloid Leukemia, Non-Hodgkin Lymphoma, Colorectal Cancer, Diffuse Large B-cell Lymphoma, Myelodysplastic Syndromes, Non-Small Cell Lung Cancers, Ovarian Epithelial Cancer, Oral mucositis, Small Cell Lung Cancers, Other Diseases Indications), By
CD47 Targeting Therapeutics Market Future Trends and Scope Analysis Report
Insight Analytics Pvt. Ltd. announces the release of a market assessment report on the "Global CD47 Targeting Therapeutics Market- by Target Disease Indication (Acute Myeloid Leukemia, Non-Hodgkin Lymphoma, Colorectal Cancer, Diffuse Large B-cell Lymphoma, Myelodysplastic Syndromes, Non-Small Cell Lung Cancers, Ovarian Epithelial Cancer, Oral mucositis, Small Cell Lung Cancers and Other Diseases Indications), Type of Molecule (Biologics and Small Molecule), Trends, Industry Competition Analysis, Revenue and Forecast To 2030." According to
Future Directions in CD47 Research: Innovations and Clinical Translation
CD47, a protein that plays a critical role in immune evasion by tumor cells, has emerged as a key target in cancer research. Its ability to interact with signal regulatory protein alpha (SIRPα) on macrophages, delivering a "don't eat me" signal that prevents the phagocytosis of tumor cells, has made it a focal point for therapeutic development. As research into CD47 progresses, several innovative approaches and clinical translation efforts are
CD47 Targeting Therapeutics Market Future Trends and Scope Analysis Report
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "Global CD47 Targeting Therapeutics Market By Target Disease Indication (Acute Myeloid Leukemia, Non-Hodgkin Lymphoma, Colorectal Cancer, Diffuse Large B-cell Lymphoma, Myelodysplastic Syndromes, Non-Small Cell Lung Cancers, Ovarian Epithelial Cancer, Oral mucositis, Small Cell Lung Cancers, Other Diseases Indications), By Type of molecule(Biologics, Small molecule) - Market Outlook and Industry Analysis 2030" According to the latest research